Inflammatory marker levels and prediction of patient-reported symptoms in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy

被引：0
|
作者：
Wang, Xin Shelley
Shi, Qiuling
Li, Donghui
Eng, Cathy
Bokhari, Raza H.
Fogelman, David R.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e20699
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20699
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Patient-reported symptoms from patients with advanced pancreatic cancer undergoing gemcitabine-based chemotherapy.
    Wang, Xin Shelley
    Fogelman, David R.
    Shi, Qiuling
    Eng, Cathy
    Bokhari, Raza H.
    Huang, Furong
    Mobley, Gary M.
    Gilmore, Katherine R.
    Cleeland, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [2] Comorbidity, not age, is prognostic in patients with advanced pancreatic cancer receiving gemcitabine-based chemotherapy
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Sasahira, Naoki
    Tsujino, Takeshi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Yashima, Yoko
    Togawa, Osama
    Arizumi, Toshihiko
    Matsubara, Saburo
    Hirano, Kenji
    Tada, Minoru
    Omata, Masao
    Koike, Kazuhiko
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2011, 78 (03) : 252 - 259
  • [3] Gemcitabine-based Adjuvant Chemotherapy for Patients with Advanced Gallbladder Cancer
    Nakamura, Masafumi
    Nakashima, Hiroshi
    Abe, Toshiya
    Ensako, Takaaki
    Yoshida, Koji
    Hino, Keisuke
    ANTICANCER RESEARCH, 2014, 34 (06) : 3125 - 3129
  • [4] Gemcitabine-based chemotherapy in advanced-metastatic and/or unresectable pancreatic cancer.
    Samelis, GF
    Areovimata, A
    Matsiakou, F
    Zografos, G
    Papakostas, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 376S - 376S
  • [5] Gemcitabine-based Concurrent Chemoradiotherapy Versus Chemotherapy Alone in Patients with Locally Advanced Pancreatic Cancer
    Wang, Bu-Hai
    Cao, Wen-Miao
    Yu, Jie
    Wang, Xiao-Lei
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (05) : 2129 - 2132
  • [6] Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.
    Nio, K.
    Ueno, H.
    Okusaka, T.
    Morizane, C.
    Hagihara, A.
    Kondo, S.
    Mayahara, H.
    Ito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Timing of chemotherapy-induced neutropenia: the prognostic factor in advanced pancreatic cancer patients treated with gemcitabine / gemcitabine-based chemotherapy
    Chen, Yang
    Shi, Yan
    Yan, Huan
    Wang, Yan Rong
    Dai, Guang Hai
    ONCOTARGET, 2017, 8 (39) : 66593 - 66600
  • [8] Helical tomotherapy and concurrent gemcitabine-based chemotherapy for locally advanced pancreatic cancer
    Seong, Jinsil
    Chang, Jisuk
    Song, Siyoung
    Keum, Woong
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [9] Profile Comparison of Patient-Reported and Proxy-Reported Symptoms in Pediatric Patients With Cancer Receiving Chemotherapy
    Weaver, Meaghann S.
    Jacobs, Shana S.
    Withycombe, Janice S.
    Wang, Jichuan
    Greenzang, Katie A.
    Baker, Justin N.
    Hinds, Pamela S.
    JAMA NETWORK OPEN, 2022, 5 (03)
  • [10] Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer
    Marechal, Raphael
    Demols, Anne
    Gay, France
    de Maertelaer, Viviane
    Arvanitaki, Marianna
    Hendlisz, Alain
    Van Laethem, Jean-Luc
    PANCREAS, 2008, 36 (03) : E16 - E21
12345